Minimal Residual Disease in Colorectal Cancer: Are We Finding the Needle in a Haystack?

Despite significant advances in the surgical and systemic therapy of colorectal cancer (CRC) in recent decades, recurrence rates remain high. Apart from microsatellite instability status, the decision to offer adjuvant chemotherapy to patients with CRC is solely based on clinicopathologic factors, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jácome, Alexandre A., Johnson, Benny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092948/
https://www.ncbi.nlm.nih.gov/pubmed/37048141
http://dx.doi.org/10.3390/cells12071068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092948/
https://www.ncbi.nlm.nih.gov/pubmed/37048141
http://dx.doi.org/10.3390/cells12071068

Ejemplares similares